Publications
WHO COVID-19 therapeutic guidelines – authors' reply
White, N., Strub-Wourgaft, N., Faiz, A., & Guerin, P. (2021). Lancet, 398(10295), 118-118.
Acute Ischemic Stroke- A presenting feature of SARS-CoV-2 infection
Paul, S., Rahman, S., Chowdhury, F., Alam, R., & Chowdhury, F. (2021). Bangabandhu Sheikh Mujib Medical University Journal, 60-63.
Association of HLA‐DRB1*09:01 with severe COVID‐19
Anzurez, A., Naka, I., Miki, S., Nakayama‐Hosoya, K., Isshiki, M., Watanabe, Y., Nakamura‐Hoshi, M., Seki, S., Matsumura, T., Takano, T., Onodera, T., Adachi, Y., Moriyama, S., Terahara, K., Tachikawa, N., Yoshimura, Y., Sasaki, H., Horiuchi, H., Miyata, N., … Kawana‐Tachikawa, A. (2021). HLA, 98(1), 37-42.
The human microbiome and COVID-19: A systematic review
Yamamoto, S., Saito, M., Tamura, A., Prawisuda, D., Mizutani, T., & Yotsuyanagi, H. (2021). PLOS ONE, 16(6), e0253293.
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Guérin, P., McLean, A., Rashan, S., Lawal, A., Watson, J., Strub-Wourgaft, N., & White, N. (2021).
Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infections
Hoque, A., Rahman, M., Imam, H., Nahar, N., & Chowdhury, F. (n.d.). In medRxiv.